Novo Nordisk
NVO
NVO
734 hedge funds and large institutions have $11B invested in Novo Nordisk in 2021 Q2 according to their latest regulatory filings, with 81 funds opening new positions, 261 increasing their positions, 229 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
14% more repeat investments, than reductions
Existing positions increased: 261 | Existing positions reduced: 229
4% more funds holding
Funds holding: 705 → 734 (+29)
0.29% more ownership
Funds ownership: 14.56% → 14.85% (+0.29%)
Holders
734
Holding in Top 10
11
Calls
$65.9M
Puts
$35.4M
Top Buyers
| 1 | +$39M | |
| 2 | +$34.5M | |
| 3 | +$23.4M | |
| 4 |
Capital International Investors
Los Angeles,
California
|
+$22.7M |
| 5 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$18.3M |
Top Sellers
| 1 | -$55.8M | |
| 2 | -$47M | |
| 3 | -$28.4M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$23.2M |
| 5 |
Loomis, Sayles & Company
Boston,
Massachusetts
|
-$22.9M |